2003
DOI: 10.1128/jcm.41.7.3336-3338.2003
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Genotyping Helicobacter pylori Directly from Biopsy Specimens and Genotyping from Bacterial Cultures

Abstract: PCR for vacA and cagA genotypes of Helicobacter pylori using DNA isolated from infected gastric biopsy specimens was approximately equal to genotyping using bacterial DNA from cultures. Inconsistent results were associated with low H. pylori density in biopsies. A higher proportion of mixed infection was found when biopsies were used

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
43
2
1

Year Published

2008
2008
2013
2013

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 44 publications
(49 citation statements)
references
References 11 publications
3
43
2
1
Order By: Relevance
“…Furthermore, they observed a higher proportion of mixed H. pylori strain infection in biopsy specimens (27%) compared to cultured H. pylori strains (9%) (Park et al, 2003). Similarly, based on cagA EPIYA genotyping we detected a higher proportion of mixed H. pylori strains in biopsy specimens (24%) compared to cultured H. pylori strains (11%).…”
Section: Discussionmentioning
confidence: 67%
See 4 more Smart Citations
“…Furthermore, they observed a higher proportion of mixed H. pylori strain infection in biopsy specimens (27%) compared to cultured H. pylori strains (9%) (Park et al, 2003). Similarly, based on cagA EPIYA genotyping we detected a higher proportion of mixed H. pylori strains in biopsy specimens (24%) compared to cultured H. pylori strains (11%).…”
Section: Discussionmentioning
confidence: 67%
“…It has been discussed that PCR-based genotyping directly from biopsy specimens tend to underestimate the prevalence of H. pylori specific virulence genes (Park et al, 2003;Secka et al, 2011). This may be due to limited access of H. pylori DNA, inhibition of PCR amplification due to high level of cellular genomic DNA, other PCR inhibitors or potent nucleases in gastric biopsy specimens (Monstein et al, 2005;Park et al, 2003;Thoreson et al, 1999).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations